NEW YORK, Oct. 17 – NimbleGen Systems has added $1.5 million in a second closing of its Series B financing round, the company said on Wednesday. A $9 million first closing was announced on Sept. 11, and the recent cash infusion brings to $14 million NimbleGen’s total funds raised to date.
NimbleGen, based in Madison, Wis., produces custom high-density DNA microarrays and is developing a desktop DNA microarray synthesizer based on its proprietary maskless array synthesizer technology, according to the company. MAS uses digital light processors to synthesize oligonucleotides in situ, the firm said.
In an e-mail this week, Mike Treble, NimbleGen’s CEO, said the company had begun shipping its arrays to collaborators. Last week he said NimbleGen expects to start delivering the first synthesizers within 18 months.